About gemcitabine ph eur
Antineoplastic nucleoside analogue
Used for
- Pancreatic cancer
- Non-small-cell lung cancer
- Breast cancer
- Ovarian or bladder cancer
Usual adult dose
Usually 1,000–1,250 mg/m² by intravenous infusion on treatment days, with schedules varying by cancer and combination medicines.
Common side effects
- Low blood cell counts
- Nausea and vomiting
- Fatigue
- Rash or flu-like symptoms
Important warnings
- Can cause serious infections or bleeding through low blood counts.
- Rarely causes severe lung injury, liver injury, or kidney problems.
- Treatment requires blood-count and organ-function monitoring.
- Use only under specialist supervision; dosing depends on cancer and treatment plan.
Pregnancy
May harm an unborn baby. Avoid during pregnancy; effective contraception is recommended during treatment and for six months afterward.
Breastfeeding
Breastfeeding is not recommended during treatment and for at least one week after the final dose.
Interactions
- Radiotherapy may increase severe tissue reactions.
- Live vaccines may cause infection, especially when blood counts are low.
- Other medicines that suppress bone marrow may increase blood-related side effects.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.